Phase 2 Dose-Rising Study of SOR007 Ointment for Actinic Keratosis
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions
- Sponsors Dfb Soria
- 26 Sep 2017 According to a DFB Soria media release, the company has completed the enrollment for the second of four patient cohort in this trial.
- 19 Jun 2017 Status changed from not yet recruiting to recruiting.
- 22 Mar 2017 New trial record